annual EBITDA:
-$677.70M-$199.82M(-41.82%)Summary
- As of today (June 22, 2025), RVMD annual EBITDA is -$677.70 million, with the most recent change of -$199.82 million (-41.82%) on December 31, 2024.
- During the last 3 years, RVMD annual EBITDA has fallen by -$497.95 million (-277.03%).
- RVMD annual EBITDA is now -2171.42% below its all-time high of -$29.84 million, reached on December 31, 2017.
Performance
RVMD EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$237.04M-$24.12M(-11.33%)Summary
- As of today (June 22, 2025), RVMD quarterly EBITDA is -$237.04 million, with the most recent change of -$24.12 million (-11.33%) on March 31, 2025.
- Over the past year, RVMD quarterly EBITDA has dropped by -$98.95 million (-71.65%).
- RVMD quarterly EBITDA is now -2454.35% below its all-time high of -$9.28 million, reached on June 30, 2019.
Performance
RVMD quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$776.65M-$98.95M(-14.60%)Summary
- As of today (June 22, 2025), RVMD TTM EBITDA is -$776.65 million, with the most recent change of -$98.95 million (-14.60%) on March 31, 2025.
- Over the past year, RVMD TTM EBITDA has dropped by -$233.30 million (-42.94%).
- RVMD TTM EBITDA is now -7216.51% below its all-time high of -$10.62 million, reached on December 31, 2018.
Performance
RVMD TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
RVMD EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -41.8% | -71.7% | -42.9% |
| 3 y3 years | -277.0% | -325.9% | -288.5% |
| 5 y5 years | -1294.8% | -1172.5% | -1241.1% |
RVMD EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -277.0% | at low | -325.9% | at low | -288.5% | at low |
| 5 y | 5-year | -1294.8% | at low | -1172.5% | at low | -1241.1% | at low |
| alltime | all time | -2171.4% | at low | -2454.3% | at low | -7216.5% | at low |
RVMD EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$237.04M(+11.3%) | -$776.65M(+14.6%) |
| Dec 2024 | -$677.70M(+41.8%) | -$212.92M(+23.2%) | -$677.70M(+5.6%) |
| Sep 2024 | - | -$172.84M(+12.3%) | -$641.90M(+8.8%) |
| Jun 2024 | - | -$153.85M(+11.4%) | -$590.17M(+8.6%) |
| Mar 2024 | - | -$138.10M(-22.0%) | -$543.35M(+13.7%) |
| Dec 2023 | -$477.88M(+92.2%) | -$177.13M(+46.3%) | -$477.88M(+32.8%) |
| Sep 2023 | - | -$121.10M(+13.2%) | -$359.86M(+15.0%) |
| Jun 2023 | - | -$107.02M(+47.4%) | -$312.86M(+17.8%) |
| Mar 2023 | - | -$72.62M(+22.9%) | -$265.59M(+6.8%) |
| Dec 2022 | -$248.62M(+38.3%) | -$59.11M(-20.2%) | -$248.62M(+3.5%) |
| Sep 2022 | - | -$74.10M(+24.0%) | -$240.13M(+10.5%) |
| Jun 2022 | - | -$59.76M(+7.4%) | -$217.22M(+8.7%) |
| Mar 2022 | - | -$55.66M(+10.0%) | -$199.92M(+11.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$179.75M(+76.4%) | -$50.61M(-1.1%) | -$179.75M(+11.5%) |
| Sep 2021 | - | -$51.19M(+20.6%) | -$161.26M(+18.9%) |
| Jun 2021 | - | -$42.46M(+19.6%) | -$135.65M(+14.2%) |
| Mar 2021 | - | -$35.49M(+10.5%) | -$118.77M(+16.5%) |
| Dec 2020 | -$101.91M(+109.7%) | -$32.13M(+25.6%) | -$101.91M(+16.0%) |
| Sep 2020 | - | -$25.57M(-0.0%) | -$87.87M(+18.4%) |
| Jun 2020 | - | -$25.58M(+37.3%) | -$74.21M(+28.2%) |
| Mar 2020 | - | -$18.63M(+3.0%) | -$57.91M(+19.2%) |
| Dec 2019 | -$48.59M(+21.7%) | -$18.08M(+51.7%) | -$48.59M(+18.2%) |
| Sep 2019 | - | -$11.92M(+28.4%) | -$41.12M(+40.8%) |
| Jun 2019 | - | -$9.28M(-0.3%) | -$29.20M(+46.6%) |
| Mar 2019 | - | -$9.31M(-12.3%) | -$19.92M(+87.7%) |
| Dec 2018 | -$39.91M(+33.8%) | -$10.62M | -$10.62M |
| Dec 2017 | -$29.84M | - | - |
FAQ
- What is Revolution Medicines annual EBITDA?
- What is the all time high annual EBITDA for Revolution Medicines?
- What is Revolution Medicines annual EBITDA year-on-year change?
- What is Revolution Medicines quarterly EBITDA?
- What is the all time high quarterly EBITDA for Revolution Medicines?
- What is Revolution Medicines quarterly EBITDA year-on-year change?
- What is Revolution Medicines TTM EBITDA?
- What is the all time high TTM EBITDA for Revolution Medicines?
- What is Revolution Medicines TTM EBITDA year-on-year change?
What is Revolution Medicines annual EBITDA?
The current annual EBITDA of RVMD is -$677.70M
What is the all time high annual EBITDA for Revolution Medicines?
Revolution Medicines all-time high annual EBITDA is -$29.84M
What is Revolution Medicines annual EBITDA year-on-year change?
Over the past year, RVMD annual EBITDA has changed by -$199.82M (-41.82%)
What is Revolution Medicines quarterly EBITDA?
The current quarterly EBITDA of RVMD is -$237.04M
What is the all time high quarterly EBITDA for Revolution Medicines?
Revolution Medicines all-time high quarterly EBITDA is -$9.28M
What is Revolution Medicines quarterly EBITDA year-on-year change?
Over the past year, RVMD quarterly EBITDA has changed by -$98.95M (-71.65%)
What is Revolution Medicines TTM EBITDA?
The current TTM EBITDA of RVMD is -$776.65M
What is the all time high TTM EBITDA for Revolution Medicines?
Revolution Medicines all-time high TTM EBITDA is -$10.62M
What is Revolution Medicines TTM EBITDA year-on-year change?
Over the past year, RVMD TTM EBITDA has changed by -$233.30M (-42.94%)